Search results for "OESO"

Locust neuropeptides stimulating sex pheromone production in female European corn borer moth, Ostrinia nubilalis

1990

Abstract The presence of a pheromonotropically active hormone (PBAN-like substance) from locust organs, ( Locusta migratoria ) has been demonstrated. Extracts of brain, corpora cardiaca, corpora allata, suboesophageal ganglia and thoracic ganglia of L. migratoria caused highly pheromonotropic responses in decapitated females of the European corn borer moth ( Ostrinia nubilalis ). The highest activity per unit weight of tissue was found in the corpora cardiaca and corpora allata of the locust followed by the brain plus suboesophageal ganglion of O. nubilalis . Following 8 days of disconnection, separating the corpora allata from the corpora cardiaca and suboesophageal ganglion, the pheromono…

Tratamiento quirúrgico de la enfermedad por reflujo gastroesofágico. Valoración de resultados y estado actual de las indicaciones

2015

1. PLANTEAMIENTO DEL PROBLEMA La Enfermedad por Reflujo Gastro-Esofágico (ERGE) constituye una entidad de elevada prevalencia en la población general (7’7 %). Su tratamiento desde que Nissen realizara en 1956 la primera funduplicatura, ha sufrido muchos vaivenes, debido a la aparición de fármacos antisecretores cada vez de mayor potencia, a los efectos inherentes de la cirugía (disfagia, atrapamiento aereo, imposibilidad de eructar / vomitar), y a la aparición de la funduplicatura laparoscópica (Dallemagne 1992) que supuso un cambio explosivo a favor del tratamiento quirúrgico. No obstante, a partir de 2005, tras una década de funduplicatura laparoscópica, y tras millares de enfermos interv…

Oesophageal pH/impedance monitoring in children treated for oesophageal atresia

2008

Characteristics of induced sputum in adult with mild asthma and in patients with asthma-like symptoms by gastroesophageal reflux disease.

2007

Elderly dysphagia: our 10-year experience in Presbyesophagus and Primary Presbyphagia.

2015

Learning objectives Background Findings and procedure details Conclusion Personal information References

Role of the gastroenterologist in the management of the obese patient.

2017

Obesity is a highly prevalent disease worldwide, and one in which gastroenterologists can play an important role. Some digestive diseases are more common in obese patients, and preoperative evaluation may be required in some cases. Additionally, bariatric surgery can lead to digestive complications in the short and long term that require intervention, and endoscopic treatment can be an important factor in weight loss. The aim of this review is to highlight the role of the gastroenterologist in the management of obese patients who are either scheduled for or have undergone surgical or endoscopic treatment for obesity.

Improving opportunities for effective management of gastro-oesophageal reflux disease

2002

The recent introduction of proton pump inhibitors has extraordinarily improved the therapeutic approach to gastro-oesophageal reflux disease. The concept of decreasing gastric acid secretion and increasing the pH in the lower oesophagus has been demonstrated to be therapeutically effective and the higher the level of pH achieved, the better the results. In spite of the evident efficacy of these molecules, there are still many patients who will continue to have symptoms despite medical treatment. Proton pump inhibitors suppress gastric acidity, but this effect shows a remarkable interindividual variation depending on different reasons. Thus, it is still possible to optimise medical therapy f…

The course of oesophagogastric varices in patients with cirrhosis after DAA-induced HCV clearance

2018

Background and aims: Use of direct acting antivirals (DAAs) has allowed to clear HCV in almost all patients even in the presence of advanced cirrhosis. Although it has been suggested that cirrhotic portal hypertension may regress after SVR, the ultimate effect of HCV clearance on the development and progression of oesophagogastric varices (OV) is still unexplored. We assessed in a prospective cohort of patients with cirrhosis the evolution of endoscopic features of portal hypertension induced by SVR obtained with DAAs. Method: 321 consecutive patients (mean age: 65.1 ± 10.5, males: 58%) with HCV Child-Pugh A cirrhosis treated with DAAs were enrolled between January 2015 and May 2016. All pa…

The treatment of portal hypertension: a meta-analytic review.

1995

Role of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography in gastrointestinal cancers

2015

AbstractFluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) has become a routine imaging modality for many malignancies and its use is currently increasing. In the present review article, we will summarize the evidence for FDG-PET/CT use in digestive cancers (excluding neuroendocrine tumours), and review the existing recommendations. While PET/CT is nowadays considered to be an important tool in the initial workup of oesophageal and anal cancers, new data are emerging regarding its use in assessing therapeutic efficacy, radiotherapy treatment planning, and detection of recurrence in case of isolated tumour marker elevation. Moreover, PET/CT may help …